Trial Profile
Evaluation of the Role of Intravitreal Injection of TPA in Treatment of Refractory Diabetic Macular Edema.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Alteplase (Primary) ; Bevacizumab
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 01 Nov 2011 Results published in Retina.
- 14 Jun 2010 New trial record